Helping psychiatric teams offer proven medicines for alcohol use disorder
External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
This project is trying ways to help psychiatrists and their teams offer FDA-approved medicines for alcohol use disorder to people with serious mental illness who drink heavily.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11195626 on NIH RePORTER |
What this research studies
Researchers will partner with psychiatric clinics to provide external facilitation—coaching, workflow support, and training—to prescribers and clinical teams so they can offer medications for alcohol use disorder (MAUD) within routine psychiatric care. The project will pilot these implementation strategies in clinics that treat people with major depressive, bipolar, schizophrenia-spectrum, and PTSD diagnoses who also have AUD. Investigators will track changes in prescribing practices, clinic processes, and access for patients, and collect feedback from clinicians and patients to refine the approach. The goal is to create practical tools and supports that make it easier for psychiatric providers to offer and monitor MAUD alongside existing psychiatric medications.
Who could benefit from this research
Good fit: Adults receiving psychiatric care who have a diagnosis of alcohol use disorder alongside major depressive disorder, bipolar disorder, schizophrenia-spectrum disorders, or PTSD are the ideal candidates for this work.
Not a fit: People without alcohol use problems, those already engaged in specialty addiction programs, or individuals not treated at participating psychiatric clinics may not directly benefit from this project.
Why it matters
Potential benefit: If successful, more patients with serious mental illness and alcohol problems could receive effective FDA-approved medications and more coordinated care within their psychiatric clinics.
How similar studies have performed: Other implementation facilitation programs have improved uptake of evidence-based treatments in clinical settings, but applying these methods specifically to increase MAUD prescribing in psychiatric clinics is relatively new.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Bennett, Melanie E. — University of Maryland Baltimore
- Study coordinator: Bennett, Melanie E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.